Intrinsic Value of S&P & Nasdaq Contact Us

Covalon Technologies Ltd. CVALF OTC

Other OTC • Healthcare • Biotechnology • CA • USD

SharesGrow Score
70/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — CVALF

Covalon Technologies Ltd. (CVALF) has a market capitalization of $40.05M and trades at $1.45. The 52-week range is 1.16-2.14.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of 19.3, Earnings Per Share (EPS) of $0.08, annual revenue of $32.82M.

The stock has a beta of -0.01, a last dividend of $0.1063, operates in the Healthcare sector.

Trading Data
Current Price$1.45
52-Week Range1.16-2.14
Volume600
Avg Volume (30D)7.03K
Market Cap$40.05M
Beta (1Y)-0.01
Last Dividend$0.1063
Company
IPO Date2007-04-18
CEOBrent Ashton
CountryCA
ExchangeOther OTC
CurrencyUSD
ISINCA22282D3022
Income (Latest Year)
Revenue$32.82M
Gross Profit$17.47M
EBITDA$2.72M
Operating Income$1.76M
Net Income$2.06M
EPS$0.08
EPS Diluted$0.07
Shares Outstanding$27.41M
Balance Sheet (Latest Year)
Total Assets$36.12M
Current Assets$31.53M
Cash & ST Investments$17.37M
Total Liabilities$5.4M
Total Debt$2.25M
Net Debt$-15.11M
Total Equity$30.73M
Debt / Equity0.07
Valuation Ratios
P/E Ratio19.3
P/S Ratio1.22
P/B Ratio1.3
EV/EBITDA (approx)14.7
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message